Home › Bladder Cancer › Kansas
Bladder Cancer clinical trials in Kansas
15 studies for Bladder Cancer are looking for participants at sites in Kansas.
Cities in Kansas
- Kansas City10 studies
- Topeka4 studies
- Overland Park4 studies
- Lawrence3 studies
- Pittsburg3 studies
- Wichita3 studies
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- and 4 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03866382A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- The University of Kansas - Clinical Research Center, Fairway
- The University of Kansas Hospital Cambridge North Tower A, Kansas City
- The University of Kansas Hospital, Kansas City
- and 3 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07206225Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- and 4 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Central Care Cancer Center - Garden City, Garden City
- University of Kansas Cancer Center, Kansas City
- Lawrence Memorial Hospital, Lawrence
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT07097142Measuring Surgical Recovery After Radical Cystectomy
- University of Kansas Medical Center, Lawrence
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT03193970DESTINY-PANTUMOUR04
- Research Site, Topeka
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Wichita Urology Group, Wichita
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06567743A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Kansas Cancer Center, Kansas City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- University of Kansas Medical Center, Kansas City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- The University of Kansas Cancer Center, Investigational Drug Services, Fairway
- The University of Kansas Clinical Research Center, Fairway
- The University of Kansas Hospital, Kansas City
- and 6 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT04389632Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Instititute - South, Overland Park
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)
- University of Kansas Medical Center, Kansas City
- University of Kansas Medical Center, Kansas City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 20, 2026 · NCT06721260Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
- University of Kansas Medical Center, Kansas City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 10, 2026 · NCT03413982Blue Light Cystoscopy With Cysview® Registry
- University of Kansas Medical Center, Kansas City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT02660645Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
- The University of Kansas Cancer Center, Kansas City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 20, 2025 · NCT06493370From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.